Brian J. Lavey

发表

Catalytic Antibody Mediated Hydrolysis of Paraoxon.

Kim D. Janda, Brian J. Lavey, 1996, The Journal of organic chemistry.

Pharmacological characterization of human S1P4 using a novel radioligand, [4,5‐3H]‐dihydrosphingosine‐1‐phosphate

J. Fossetta, C. Lunn, D. Lundell, 2004, British journal of pharmacology.

Structure and activity relationships of tartrate-based TACE inhibitors.

P. Orth, Zhuyan Guo, C. Strickland, 2010, Bioorganic & medicinal chemistry letters.

The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors.

Patrick J. Curran, P. Orth, Zhuyan Guo, 2010, Bioorganic & medicinal chemistry letters.

A Novel Cannabinoid Peripheral Cannabinoid Receptor-Selective Inverse Agonist Blocks Leukocyte Recruitment in Vivo

Jay S. Fine, S. Narula, J. Jackson, 2006, Journal of Pharmacology and Experimental Therapeutics.

Triaryl bis-sulfones as cannabinoid-2 receptor ligands: SAR studies.

Jie Wu, C. Lunn, N. Shih, 2005, Bioorganic & medicinal chemistry letters.

Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists

C. Lunn, D. Lundell, Brian J. Lavey, 2008, British journal of pharmacology.

A novel cannabinoid CB 2 receptor-selective inverse agonist blocks leukocyte recruitment in vivo

S. Narula, J. Jackson, C. Lunn, 2005 .

Triaryl bis-sulfones as a new class of cannabinoid CB2 receptor inhibitors: identification of a lead and initial SAR studies.

S. Narula, C. Lunn, D. Lundell, 2005, Bioorganic & medicinal chemistry letters.

Cannabinoid CB(2)-selective inverse agonist protects against antigen-induced bone loss.

J. Jackson, C. Lunn, D. Lundell, 2007, Immunopharmacology and immunotoxicology.

Cannabinoid CB2-Selective Inverse Agonist Protects Against Antigen-Induced Bone Loss

C. Lunn, J. Fine, Brian J. Lavey, 2007 .

Discovery and SAR of hydantoin TACE inhibitors.

S. Umland, P. Orth, Zhuyan Guo, 2010, Bioorganic & medicinal chemistry letters.

Substituted tetracyclic indole core derivatives of HCV NS5A inhibitor MK-8742.

E. Asante-Appiah, C. Coburn, M. Dwyer, 2016, Bioorganic & medicinal chemistry letters.

Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors. Part II: optimization of the S3' pocket.

Brian McKittrick, Zhuyan Guo, Xiaoda Niu, 2008, Bioorganic & medicinal chemistry letters.

Selective benzylic lithiation of N-Boc-2-phenylpiperidine and pyrrolidine: expedient synthesis of a 2,2-disubstituted piperidine NK1 antagonist

J. Lachowicz, A. Palani, A. McPhail, 2005 .